[HTML][HTML] Hepatectomy-induced alterations in hepatic perfusion and function-toward multi-scale computational modeling for a better prediction of post-hepatectomy liver …

B Christ, M Collatz, U Dahmen, KH Herrmann… - Frontiers in …, 2021 - frontiersin.org
Liver resection causes marked perfusion alterations in the liver remnant both on the organ
scale (vascular anatomy) and on the microscale (sinusoidal blood flow on tissue level) …

Citrullinated histone H3: early biomarker of neutrophil extracellular traps in septic liver damage

K Nomura, T Miyashita, Y Yamamoto… - Journal of Surgical …, 2019 - Elsevier
Abstract Background Neutrophil extracellular traps (NETs) play a crucial role in host
defense, but excess and prolonged interaction of NETs with platelets can cause severe …

Cilostazol induces apoptosis and inhibits proliferation of hepatocellular carcinoma cells by activating AMPK

KH Sim, MS Shu, S Kim, JY Kim, BH Choi… - Biotechnology and …, 2021 - Springer
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and one of the
leading causes of cancer-related death. Cilostazol, an antiplatelet drug, elicits anticancer …

[HTML][HTML] Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway

YJ Lee, MS Shu, JY Kim, YH Kim, KH Sim, WJ Sung… - PLoS …, 2019 - journals.plos.org
Alcoholic liver disease (ALD) is a worldwide health problem and hepatocyte apoptosis has
been associated with the development/progression of ALD. However, no definite effective …

Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome

H Sugita, S Nakanuma, S Munesue… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim Safe radical hepatectomy is important for patients with
colorectal liver metastases complicated by sinusoidal obstruction syndrome (SOS) after …

Oral administration of cilostazol improves survival rate after rat liver ischemia/reperfusion injury

T Fujii, H Obara, K Matsubara, N Fujimura… - Journal of Surgical …, 2017 - Elsevier
Background Cilostazol is a type III phosphodiesterase inhibitor used to treat the symptoms of
intermittent claudication. Recent studies have shown that cilostazol decreases …

肝硬化肝再生的研究进展

吴心强, 陈亚进 - 中华消化外科杂志, 2017 - cqvip.com
正常肝再生能力强大, 而肝硬化肝再生能力低下, 肝功能储备不足, 致使肝切除术后肝衰竭发生率
大大增加, 限制了大范围肝切除术的开展. 肝硬化肝细胞虽具有再生能力, 但受到抑制 …

Organic Anion–Transporting Polypeptide and Efflux Transporter–Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans

C Wang, X Huo, C Wang, Q Meng, Z Liu, P Sun… - Journal of …, 2017 - Elsevier
Cilostazol undergoes extensive liver metabolism. However, the transporter-mediated
hepatic disposition of cilostazol remains unknown. The present study was performed to …

[PDF][PDF] The effects of ursodeoxycholic acid pretreatment in an experimental setting of extended hepatectomy: a feasibility study

A Paspala, D Papakonstantinou, A Prodromidou… - Cureus, 2020 - cureus.com
Liver regeneration is an exceptionally complex process, orchestrated by a multitude of
growth factors and cytokines. Tumor necrosis factor-alpha (TNF-a) and interleukin-6 (Il-6) …

[PDF][PDF] Daily Dose of 5 mg Tadalafil Safely Improves Erectile Function and Liver Function Enzymes in Smokers

DS Kwak, BW Yoo - Journal of Men's Health, 2022 - article.imrpress.com
Background: Smokers are known to have a higher risk of erectile dysfunction. We examined
how daily consumption of low-dose tadalafil affected erectile function and circulation in …